- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 281/10 - Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
Patent holdings for IPC class C07D 281/10
Total number of patents in this class: 141
10-year publication summary
12
|
6
|
1
|
9
|
9
|
13
|
16
|
12
|
8
|
3
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Albireo AB | 170 |
31 |
Elobix AB | 17 |
15 |
Glaxosmithkline Intellectual Property (no.2) Limited | 287 |
9 |
RyCarma Therapeutics, Inc. | 23 |
9 |
Armgo Pharma, Inc. | 13 |
8 |
Glaxosmithkline Intellectual Property Development Limited | 761 |
7 |
Shire Human Genetic Therapies, Inc. | 190 |
5 |
VALO Health, Inc. | 172 |
3 |
Novartis AG | 10829 |
2 |
Glaxosmithkline LLC | 536 |
2 |
Merck Sharp & Dohme Corp. | 2190 |
2 |
Apeiron Biologics AG | 32 |
2 |
Assembly Biosciences, Inc. | 77 |
2 |
KYORIN Pharmaceutical Co., Ltd. | 167 |
2 |
Les Laboratoires Servier | 540 |
2 |
Shanghai Institute of Pharmaceutical Industry | 129 |
2 |
HK Inno.n Corporation | 108 |
2 |
Shanghai Zhongze Therapeutics, Co. Ltd. | 5 |
2 |
Hainan Jin Rui Pharmaceutical Co., Ltd. | 8 |
2 |
Bristol-myers Squibb Company | 4884 |
1 |
Other owners | 31 |